Albumin binding peptide-mediated disease targeting

Details Albumin binding peptide-mediated disease targeting Albumin binding peptide-mediated disease targeting

A - Human Necessities

61

K

A61K 47/48 (2006.01) A61K 39/44 (2006.01) A61K 47/42 (2006.01) A61K 49/00 (2006.01) A61K 51/08 (2006.01)

Patent

CA 2745899

The invention provides compositions and methods for delivering a therapeutic or diagnostic agent to a disease site m a mammal, the method comprising administering to the mammal a therapeutically or diagnostically effective amount of a phar-maceutical composition, wherein the pharmaceutical composition comprises the therapeutic or diagnostic agent coupled to an al-bumin binding peptide and a pharmaceutically acceptable carrier.

L'invention concerne des compositions et des procédés d'administration d'un agent thérapeutique ou diagnostique à un site de maladie chez un mammifère. Le procédé consiste à administrer au mammifère une quantité efficace d'un point de vue thérapeutique ou diagnostique d'une composition pharmaceutique, ladite composition comportant l'agent thérapeutique ou diagnostique couplé à un peptide de liaison à l'albumine et un vecteur de qualité pharmaceutique.

Affiliated with

Also associated with

Rating

Albumin binding peptide-mediated disease targeting does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Albumin binding peptide-mediated disease targeting, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Albumin binding peptide-mediated disease targeting will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1776717